Companies: 10,795·Total market cap: $144.5T

Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTUNASDAQHealthcare● Active

$1.82

$-0.06(-3.19%)

Market Cap$43545051

P/E Ratio—

52W High$9.35

52W Low$1.58

Avg Volume144K

Open$1.94

Beta0.53

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Actuate Therapeutics Inc（ACTU）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ACTU · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.99Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding21.0MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Actuate Therapeutics Inc 数据

分析师预测$21 · Buy

股息不分红

盈利EPS $-1.06+67.48%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$22.2M▲ +18.54% YoY

202320242025

FY 2025EPS$-1.06▲ +67.48% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$21.5MEPS: $-0.99View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$21.00Low

$1.82Current

$21.00Avg Target上涨空间 1053.85%

$21.00High

合计: 1 · 买入占比: 100.0%

根据过去 3 个月内 1 位华尔街分析师，ACTU 共识评级为 Buy，12 个月平均目标价 $21.00 （较现价 $1.82 上涨空间 1053.85%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Actuate Therapeutics Inc

$1.82-3.19%$43.5M #2

$1.64+0.31%$182.1M #3

Applied Therapeutics, Inc.

$0.10+0.00%$14.9M #4

Elicio Therapeutics, Inc.

$13.55+2.19%$258.6M #5

Seres Therapeutics, Inc.

$6.28-5.28%$60.8M #6

Molecular Partners AG

$3.95-3.66%$148.2M

股票表现

1D-3.19%

1W-3.70%

1M-44.85%

3M-36.36%

YTD-70.26%

1Y-79.10%

5Y-78.86%

关于 Actuate Therapeutics Inc

CEODaniel Schmitt

IPO DateAug 13, 2024

Employees10

CountryUS

Websiteactuatetherapeutics.com

Actuate Therapeutics Inc Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an inn…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Actuate Therapeutics Inc（ACTU）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 13, 2024 在 NASDAQ 上市。截至最近交易日，ACTU 股价为 $1.82，市值约为 $43.5M。过去12个月累计回报 -79.10%，年初至今回报 -70.26%。

根据 1 位华尔街分析师，Actuate Therapeutics Inc 股票共识评级为Buy，12个月平均目标价为 $21.00。2025 财年 Actuate Therapeutics Inc 营收 —，净利润 -$22.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Actuate Therapeutics Inc（ACTU）股价为 $1.82，在 NASDAQ 上市，52周区间为 $1.58 – $9.35。

ACTU 最新股价ACTU quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议